Scale Solutions vs. Telehealth GLP-1 Programs: An Honest Comparison for Savannah-Area Patients

Reviewed by Donald L. Gates, MD — Bariatric Medicine, practicing since 1999

If you are researching GLP-1 weight loss medications, you have options — and the landscape is more crowded than it was two years ago. Telehealth platforms like Hims/Hers, Found, Noom Med, Henry Meds, and Sequence (now part of WeightWatchers Clinic) are competing directly with local physician practices for the same patients. Before you choose, you deserve a clear-eyed comparison that acknowledges what each model does well and what each one misses.

This comparison is written from the perspective of an in-person physician practice — we are not a neutral party. But we will try to be honest. Telehealth gets some things right, and we will say so. In-person care gets other things right, and we will explain why those things matter for specific patients.

What Telehealth Gets Right

Telehealth weight loss programs exist because they solve real problems that the traditional healthcare system created. Before giving any critique, it is worth being fair about what they do well:

Convenience

For a working adult who cannot easily take time off during clinic hours, the ability to have a medication consultation from their phone during a lunch break is genuinely valuable. Telehealth eliminates travel time, parking, waiting rooms, and the scheduling friction of a traditional practice.

Scale and Access

In rural or underserved areas where there is no local bariatric medicine specialist, telehealth platforms provide access to medications and clinical oversight that patients would otherwise be unable to obtain. This is not a trivial benefit — it has brought effective treatment to patients who would have remained untreated.

Price Transparency (Sometimes)

Some telehealth platforms offer straightforward subscription pricing that patients find easier to budget around than the variable costs of insurance-dependent in-person care. For simple cases in younger, lower-BMI patients with no comorbidities, the telehealth value proposition is often reasonable.

Where Telehealth Works Best

A healthy 33-year-old with a BMI of 28, no significant comorbidities, and a well-established primary care provider for everything else is a reasonable candidate for telehealth GLP-1 prescribing. The clinical complexity is low, the monitoring needs are straightforward, and the convenience advantages are real.

What Telehealth Misses — and Why It Matters

No Physical Examination

A telehealth consultation does not include a physical examination. This means no abdominal palpation, no assessment of lymph nodes or thyroid, no blood pressure measurement, no listening to heart sounds, no evaluation of lower extremity edema, no assessment of grip strength or muscle mass. For a patient with multiple comorbidities, elevated cardiovascular risk, or a complex medication list, these omissions are not theoretical concerns — they are clinical gaps that matter.

The physical examination is not theater. It is how physicians find things that patients do not know to report and that blood tests do not capture.

No In-Person Labs

Most telehealth platforms require or recommend lab work, but they do not perform it in-office. They send you to a third-party lab facility, which means an additional appointment, additional travel, and — for some platforms — no clear integration of results into the prescribing physician’s workflow. Some telehealth programs prescribe without requiring baseline labs at all, which is clinically concerning for patients with undiagnosed diabetes, thyroid disease, or kidney function abnormalities.

Asynchronous Care Means Slower Escalation

Telehealth platforms are often asynchronous — you message a provider and receive a response later. For routine prescription refills, this works. For a patient experiencing significant nausea, pancreatitis-like pain, or a worrying blood pressure change, asynchronous messaging is a poor substitute for a same-day call or an in-office evaluation. When something goes wrong, response time matters.

No In-Network Insurance Billing for Most Platforms

The major telehealth GLP-1 platforms generally operate outside traditional insurance networks. They are cash-pay services, sometimes with their own financing options. This means patients do not benefit from insurance negotiated rates on lab work, office visits, or specialist referrals. It also means that if you develop a complication requiring specialist care — a gastroenterologist for severe GI symptoms, an endocrinologist for complex metabolic issues — the telehealth platform cannot directly refer you within a covered network.

No Drug Continuity If You Need to Switch

Some telehealth platforms specialize in one medication and have limited flexibility if that medication is unavailable, causes intolerable side effects, or is not covered by your insurance. In-person physician practices with formulary flexibility can pivot between semaglutide and tirzepatide, adjust dosing more granularly, and coordinate with local pharmacies to solve access problems — including when there are supply interruptions.

Provider Continuity and Relationship

Many telehealth programs use rotating provider pools — the clinician who reviews your message today may not be the same clinician who reviewed your intake, and may not be the same clinician who handles your question next month. For chronic disease management, this matters. Obesity is a chronic condition. Treatment decisions benefit from a provider who knows your history, your prior response patterns, your comorbidities, and your life context.

The Scale Solutions Experience

Scale Solutions is a physician-led practice built around a single physician: Dr. Donald L. Gates, MD, who has been practicing bariatric medicine since 1999. That continuity is not incidental — it is the practice model.

When you come to Scale Solutions, Dr. Gates sees you. At your first visit and at follow-up visits. You are not rotating through a care team or corresponding with a messaging queue. You are seeing the same physician who has been managing metabolic disease in coastal Georgia for over two decades.

The practice includes:

• In-office lab capability — bloodwork ordered and processed without requiring a separate facility trip
• Physical examination at each visit — blood pressure, relevant physical findings, body composition markers
• A family medicine background that allows Dr. Gates to manage co-occurring conditions in the same clinical relationship, rather than siloing weight management from the rest of your health
• Local pharmacy relationships in Savannah, Pooler, and Hinesville that can help navigate formulary issues, prior authorizations, and supply disruptions
• Spanish-language consultations available
• Three locations: Savannah, Pooler, and Hinesville — covering the full coastal Georgia patient population

Comparison Table: Scale Solutions vs. Major Telehealth Platforms

Note: Telehealth platform offerings change frequently. Verify current policies and formulary options directly with each provider. This comparison reflects generally available public information as of 2025-2026.

Where Telehealth Wins — Honestly

This is the section that most in-person practices would skip. We will not.

If you are under 40, your BMI is between 27 and 30, you have no significant comorbidities, you already have a primary care provider managing your other health needs, and the nearest Scale Solutions location is inconvenient for you — a telehealth platform is a reasonable starting point. The clinical complexity of your case is low, the monitoring needs are manageable remotely, and the convenience advantage is real.

If geographic distance from all three Scale Solutions locations is a genuine barrier — not an inconvenience, but an actual logistical barrier — then telehealth may be your only realistic access point for GLP-1 therapy, and imperfect access is better than no access.

If price is the limiting factor: telehealth platforms, particularly those offering compounded medications, are often less expensive than branded medications accessed through in-person care. However, the regulatory landscape for compounded GLP-1 medications changed significantly in early 2025, and patients should verify the current legal status of any compounded medication before committing to a program.

Making the Right Choice for Your Situation

The question is not “which type of provider is better in the abstract” — it is “which type of provider is better for me, given my specific health situation and what I am trying to accomplish.”

For higher-BMI patients (BMI ≥ 35), patients with multiple comorbidities, patients with established cardiovascular or metabolic disease, patients on complex medication regimens, and patients who have tried and discontinued GLP-1 therapy before — in-person physician care is likely to produce better outcomes because the clinical stakes are higher and the value of physical examination, real-time monitoring, and continuity is greater.

For patients considering Scale Solutions, the first step is a consultation with Dr. Gates. Information about what that visit involves is on our about Dr. Gates page. Pricing and insurance information is on the pricing page. Location-specific information for Savannah, Pooler, and Hinesville is available on the locations page. For details on cost and insurance coverage for GLP-1 medications in Georgia, see our GLP-1 cost and insurance Georgia guide.

This page is for informational purposes only and is not medical advice. Consult Dr. Gates or another qualified clinician before starting any treatment.